Cargando…

Botulinum Neurotoxin Heavy Chain Belt as an Intramolecular Chaperone for the Light Chain

Detalles Bibliográficos
Autores principales:	Brunger, Axel T, Breidenbach, Mark A, Jin, Rongsheng, Fischer, Audrey, Santos, Jose S, Montal, Mauricio
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2007
Materias:	Opinions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994969/ https://www.ncbi.nlm.nih.gov/pubmed/17907800 http://dx.doi.org/10.1371/journal.ppat.0030113

Ejemplares similares

Beltless Translocation Domain of Botulinum Neurotoxin A Embodies a Minimum Ion-conductive Channel
por: Fischer, Audrey, et al.
Publicado: (2012)

Light Chain Diversity among the Botulinum Neurotoxins
por: Gardner, Alexander P., et al.
Publicado: (2018)

Botulinum Neurotoxin Devoid of Receptor Binding Domain Translocates Active Protease
por: Fischer, Audrey, et al.
Publicado: (2008)

Identification of Clinically Viable Quinolinol Inhibitors of Botulinum Neurotoxin A Light Chain
por: Caglič, Dejan, et al.
Publicado: (2014)

Botulinum Neurotoxin Diversity from a Gene-Centered View
por: Benoit, Roger M.
Publicado: (2018)

Neurologic uses of botulinum neurotoxin type A
por: Ney, John P, et al.
Publicado: (2007)

Neutralization of Botulinum Neurotoxin by a Human Monoclonal Antibody Specific for the Catalytic Light Chain
por: Adekar, Sharad P., et al.
Publicado: (2008)

Consensus Statement on the Use of Botulinum Neurotoxin in the Middle East
por: Ali, Shazia, et al.
Publicado: (2023)

Ergonomic Recommendations in Ultrasound-Guided Botulinum Neurotoxin Chemodenervation for Spasticity: An International Expert Group Opinion
por: Lagnau, Philippe, et al.
Publicado: (2021)

Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products
por: Frevert, Jürgen
Publicado: (2015)

Light Chain Separated from the Rest of the Type A Botulinum Neurotoxin Molecule Is the Most Catalytically Active Form
por: Gul, Nizamettin, et al.
Publicado: (2010)

Resolution of Two Steps in Botulinum Neurotoxin Serotype A1 Light Chain Localization to the Intracellular Plasma Membrane
por: Gardner, Alexander, et al.
Publicado: (2021)

How Botulinum Neurotoxin Light Chain A1 Maintains Stable Association with the Intracellular Neuronal Plasma Membrane
por: Gardner, Alexander P., et al.
Publicado: (2022)

High Sensitivity Detection of Active Botulinum Neurotoxin by Glyco-Quantitative Polymerase Chain-Reaction
por: Kwon, Seok Joon, et al.
Publicado: (2014)

Multivalent Chromosomal Expression of the Clostridium botulinum Serotype A Neurotoxin Heavy-Chain Antigen and the Bacillus anthracis Protective Antigen in Lactobacillus acidophilus
por: O'Flaherty, Sarah, et al.
Publicado: (2016)

The Effect of Botulinum Neurotoxin Serotype a Heavy Chain on the Growth Related Proteins and Neurite Outgrowth after Spinal Cord Injury in Rats
por: Wang, Ya-Fang, et al.
Publicado: (2018)

Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library
por: Miethe, Sebastian, et al.
Publicado: (2014)

Resolving the Molecular Steps in Clostridial Neurotoxin Light Chain Translocation
por: Zuverink, Madison, et al.
Publicado: (2020)

Vpu Matchmakers as a Therapeutic Strategy for HIV Infection
por: Montal, Mauricio
Publicado: (2009)

On Botulinum Neurotoxin Variability
por: Montecucco, Cesare, et al.
Publicado: (2015)

Iterative Structure-Based Peptide-Like Inhibitor Design against the Botulinum Neurotoxin Serotype A
por: Zuniga, Jorge E., et al.
Publicado: (2010)

Isolation of nanomolar scFvs of non-human primate origin, cross-neutralizing botulinum neurotoxins A(1) and A(2) by targeting their heavy chain
por: Avril, Arnaud, et al.
Publicado: (2015)

Neurotrophic effects of Botulinum neurotoxin type A in hippocampal neurons involve activation of Rac1 by the non-catalytic heavy chain (HC(C)/A)
por: Solabre Valois, Luis, et al.
Publicado: (2021)

Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?
por: Poulain, Bernard, et al.
Publicado: (2019)

Translocation of botulinum neurotoxin serotype A and associated proteins across the intestinal epithelia
por: Lam, Tina I, et al.
Publicado: (2015)

Zebrafish Sensitivity to Botulinum Neurotoxins
por: Chatla, Kamalakar, et al.
Publicado: (2016)

Use of Botulinum Neurotoxin in Ophthalmology
por: Başar, Emel, et al.
Publicado: (2016)

Antipruritic Effects of Botulinum Neurotoxins
por: Gazerani, Parisa
Publicado: (2018)

Therapy of Sialorrhea with Botulinum Neurotoxin
por: Jost, Wolfgang H., et al.
Publicado: (2019)

Botulinum neurotoxins: Future innovations
por: Brideau-Andersen, Amy, et al.
Publicado: (2023)

Conjugative Botulinum Neurotoxin-Encoding Plasmids in Clostridium botulinum
por: Marshall, Kristin M., et al.
Publicado: (2010)

Botulinum Neurotoxin A Complex Recognizes Host Carbohydrates through Its Hemagglutinin Component
por: Yao, Guorui, et al.
Publicado: (2014)

Intermolecular versus intramolecular interactions of Dictyostelium myosin: possible regulation by heavy chain phosphorylation
Publicado: (1989)

The Light Chain Domain and Especially the C-Terminus of Receptor-Binding Domain of the Botulinum Neurotoxin (BoNT) Are the Hotspots for Amino Acid Variability and Toxin Type Diversity
por: Tian, Renmao, et al.
Publicado: (2022)

Probing the structure and function of the protease domain of botulinum neurotoxins using single-domain antibodies
por: Lam, Kwok-ho, et al.
Publicado: (2022)

Emerging Opportunities for Serotypes of Botulinum Neurotoxins
por: Peng Chen, Zhongxing, et al.
Publicado: (2012)

Engineering of Botulinum Neurotoxins for Biomedical Applications
por: Webb, Robert P.
Publicado: (2018)

The Expanding Therapeutic Utility of Botulinum Neurotoxins
por: Fonfria, Elena, et al.
Publicado: (2018)

Botulinum neurotoxin formulations: overcoming the confusion
por: Samizadeh, Souphiyeh, et al.
Publicado: (2018)

Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology
por: Pirazzini, Marco, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vqra66e9mhbsfemb16inajmt4b